Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 12/20 | 0.37 |
| ▸ | NR1H3 | Q13133 | 10/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7582279 | 0.94 | NR1H2 (0.33) | NR1H2NR1H3HSD11B1 | |
| SCHEMBL7557978 | 0.90 | NR1H2 (0.38) | NR1H2NR1H3PTGS2HSD11B1RXFP1 | |
| SCHEMBL13054313 | 0.90 | NR1H2 (0.38) | NR1H2NR1H3PTGS2HSD11B1RXFP1 | |
| SCHEMBL7581886 | 0.87 | KDM1A (0.34) | ESR1MEN1KMT2A | |
| SCHEMBL7588738 | 0.85 | PAX8 (0.31) | MEN1KMT2A | |
| SCHEMBL7588393 | 0.85 | P2RX7 (0.34) | KCNH2MEN1KMT2A | |
| SCHEMBL7583661 | 0.84 | PGR (0.31) | KCNH2MEN1KMT2A | |
| SCHEMBL7556803 | 0.83 | HSD11B1 (0.34) | NR1H2NR1H3HSD11B1 | |
| SCHEMBL14105059 | 0.83 | HSD11B1 (0.34) | NR1H2NR1H3HSD11B1 | |
| SCHEMBL13054244 | 0.83 | HSD11B1 (0.34) | NR1H2NR1H3HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8183252-B2 | Heterocyclic aspartyl protease inhibitors | SCHERING CORPORATION (US) | 2012-05-22 | — | — | US | disclosed |